new_logo_final_edited.gif

GENECENTRIX INC.

  • Home

  • HistoReceptomics Platform

    • FAQ
    • Case Study
  • About Us

    • Our Team
    • Publications
  • Attrition Zero Blog

    • Contact Us
  • Contact GeneCentrix

  • More

    Use tab to navigate through the menu items.

    THE GENE

    EXPRESS

    Recent News

    Relief belief

    Relief belief

    Sick factor

    Sick factor

    Fast and spurious

    Fast and spurious

    Tags

    • Abeta
    • acute myeloid leukemia
    • ADME-Tox
    • adverse effects
    • AI
    • AIDS
    • allergies
    • Alzheimer's Disease
    • AML
    • ANA
    • anti-angiogenesis
    • anti-angiogenic
    • antibiotics
    • antidepressants
    • antiretroviral drugs
    • antiretroviral therapy
    • aortic rupture
    • ART
    • artificial intelligence
    • asthma
    • AstraZeneca
    • atrial fibrillation
    • attrition
    • attrition rate
    • autoimmune disease
    • autoimmunity
    • azithromycin
    • AZT
    • B-raf
    • big data
    • Biogen
    • biologics
    • biopharma
    • biotech
    • biotechnology
    • Braf
    • Brinavess
    • cancer
    • cancer clinical trials
    • cancer drugs
    • cancer treatment
    • cardiac cell contraction
    • Cas9
    • CCR5
    • Celgene
    • chemical database
    • chemical library
    • chemical ligands
    • chemical structure
    • chemical structures
    • cheminformatics
    • chinical trials
    • clinical hold
    • clinical testing
    • clinical trial
    • clinical trial Phase III study
    • clinical trials
    • clinicaltrials
    • clozapine
    • CNS
    • compound libraries
    • Correvio
    • COVID-19 drugs
    • COVID-19 mutation
    • COVID-19 Treatments
    • COVID-19 vaccine
    • CRISPR
    • CRISPR-Cas
    • curcumin
    • deep learning
    • DESCOVY
    • Diiachi Saykyo
    • DNA
    • DNASE1L3
    • drug
    Surface charm

    Surface charm

    A small pilot study from France showed that all six COVID-19 patients given a hydroxychloroquine/azithromycin combination recovered...
    Auld ligands syne

    Auld ligands syne

    The massive inefficiency of target-based high-throughput screening eventually led to major pivots in the pharmaceutical industry. The...
    Swede success

    Swede success

    Despite anatomy being the first topic to challenge the student in medical school for over 150 years, attention to variation of drug...
    Frag rocks

    Frag rocks

    You gotta walk before you can run. Actually, you usually have to crawl before you walk. For small molecule drug discovery in the early...
    Screen saviors

    Screen saviors

    High-throughput screening (HTS) has been a blessing and a curse. A blessing in codifying a straightforward approach to discovering drug...
    Leper known

    Leper known

    The story begins in the 1950s when thalidomide was approved as an over the counter sedative in Europe, but conspicuously rejected by the...
    Vax populi

    Vax populi

    In the 1980’s, shortly after the HIV virus was isolated as the cause of the terrifying unexplained disease AIDS, Ronald Reagan’s Health...
    Dr. Knowlittle

    Dr. Knowlittle

    This one comes out of the past, but it is about a fear as old as time . . . or at least as old as Merck, namely that testing in animals...
    Data with destiny

    Data with destiny

    Imagine you have discovered a hit compound to treat drug addiction. Before you drop $1 billion on its development, wouldn’t you want to...
    It's been a hard day's development

    It's been a hard day's development

    Pharma small molecule discovery has continued its longtime inexorable decline noted some time ago in this paper. There is little doubt...
    1
    2
     

    Get Attrition Zero, all the latest drug development news, delivered to your inbox.

    Follow us:

    ©2018-2020 GeneCentrix, Inc.                                                                            FCOI Policy